Status:
TERMINATED
Regenerative Ability of TAMP BG and BD in Pulpotomized Primary Teeth
Lead Sponsor:
Nourhan M.Aly
Collaborating Sponsors:
Alexandria University
Conditions:
Pulpotomy
Eligibility:
All Genders
5-9 years
Phase:
PHASE2
Brief Summary
The aim of this study was to assess clinically, radiographically, and histologically the regenerative ability of Tailored Amorphous Mulioporous (TAMP-BG) bioglass in comparison to Biodentine™ (BD) in ...
Detailed Description
The study was a parallel design, randomized controlled clinical trial It was conducted in the out-patient clinic of the Pediatric Dentistry and Dental public health department after obtaining the guar...
Eligibility Criteria
Inclusion
- Children free of any systemic disease or special health care needs.
- Children not receiving any anti-inflammatory medication.
- Cooperative children (positive/ definitely positive) according to Frankl's behavior rating scale.
- Restorable teeth.
- Teeth with vital carious pulp exposure that will bleed upon entering the pulp chamber and not requiring more than 5 minutes to achieve hemostasis after coronal pulp amputation.
- Teeth indicated for extraction for orthodontic purposes with the previously mentioned criteria (required for a subgroup for assessment of histological and inflammatory response outcomes).
Exclusion
- Teeth with clinical or radiographic signs of pulp degeneration.
Key Trial Info
Start Date :
December 6 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 20 2018
Estimated Enrollment :
102 Patients enrolled
Trial Details
Trial ID
NCT03786302
Start Date
December 6 2016
End Date
October 20 2018
Last Update
October 14 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Dentistry, Alexandria University
Alexandria, Egypt, 21512